The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

The Texas Education Agency said it rigorously vetted the reliability of its scoring machine before launching in 2024. Agency officials added that the system is audited and that subjective scoring is ...

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

The patent application, filed under Application Number N2039644, represents a significant step forward in the Company's intellectual property strategy. This milestone highlights Cosmos Health's ...

Lamont’s administration failed to adhere to a law that aims to increase fairness in Connecticut’s criminal justice system.

CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovativ ...

The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

The Wisconsin Rapids Legislative Committee will discuss creating an ordinance to ban added fluoride in the city's water during its meeting Tuesday.

Mumbai: Bajaj Healthcare Limited has announced that it has received approval from the Drug Controller General of India (DCGI) ...